Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ResMed | RMD | Dec 26, 2024 | 233.88 | +0.56 |
Resources Connection | RGP | Dec 26, 2024 | 8.36 | +2.96 |
Restaurant Brands International | QSR | Dec 26, 2024 | 65.84 | +0.30 |
Retail Bull 3X Direxion | RETL | Dec 26, 2024 | 10.72 | +3.78 |
Retail ETF Market Vectors | RTH | Dec 26, 2024 | 229.44 | +0.08 |
Retail Opportunity Investments | ROIC | Dec 26, 2024 | 17.35 | -0.17 |
ReTo Eco-Solutions | RETO | Dec 26, 2024 | 0.88 | -1.67 |
Retractable Technologies | RVP | Dec 26, 2024 | 0.64 | +0.09 |
REV Group | REVG | Dec 26, 2024 | 31.85 | +1.08 |
Revance Therapeutics | RVNC | Dec 26, 2024 | 3.08 | 0.00 |
Revelation Biosciences | REVB | Dec 26, 2024 | 0.35 | +17.10 |
Revelyst | GEAR | Dec 26, 2024 | 19.22 | 0.00 |
Revenueshares Largecap | RWL | Dec 26, 2024 | 99.76 | +0.21 |
Revenueshares Midcap | RWK | Dec 26, 2024 | 117.64 | +0.47 |
Revenueshares Smallcap | RWJ | Dec 26, 2024 | 46.36 | +0.94 |
Revenueshares Ultra Dividend Fund | RDIV | Dec 26, 2024 | 48.83 | +0.33 |
Reviva Pharmaceuticals | RVPH | Dec 26, 2024 | 1.86 | +4.49 |
Revolution Medicines | RVMD | Dec 26, 2024 | 45.29 | +2.03 |
Revolve Group A | RVLV | Dec 26, 2024 | 33.06 | -2.22 |
Revvity | RVTY | Dec 26, 2024 | 112.50 | +0.14 |
REX American Resources | REX | Dec 26, 2024 | 41.58 | +0.46 |
Rexford Industrial Realty | REXR | Dec 26, 2024 | 39.06 | +1.01 |
Rexford Industrial Realty B Pref | REXR-B | Dec 26, 2024 | 23.05 | -0.22 |
Rexford Industrial Realty C Pref | REXR-C | Dec 26, 2024 | 22.15 | 0.00 |
Reynolds Consumer Products | REYN | Dec 26, 2024 | 27.36 | +0.37 |
Rezolute | RZLT | Dec 26, 2024 | 5.01 | +13.61 |
Rezolve AI Limited - Ordinary Shares | RZLV | Dec 26, 2024 | 4.62 | +29.78 |
RF Acquisition A | RFAC | Dec 26, 2024 | 11.47 | 0.00 |
RF Acquisition Corp II | RFAIU | Dec 26, 2024 | 10.36 | +0.97 |
RF Acquisition II | RFAI | Dec 26, 2024 | 10.20 | +0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.